Source:http://linkedlifedata.com/resource/pubmed/id/15977645
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2005-6-27
|
pubmed:abstractText |
Neuroinflammation has an established link with AIDS-related dementia but has not been investigated in the post-highly active anti-retroviral therapy (HAART) era. In this autopsy study we examined post-HAART cases in Edinburgh for the presence of HIV-related pathology and in well-treated cases for evidence of neuroinflammation. We focused on basal ganglia and the hippocampus, 2 key areas of the brain for cognitive functioning and compared pre- and post-HAART cases for neuroinflammatory status. We find evidence, post-HAART, that there is a high level of microglial/macrophage activation that is comparable with the levels seen, pre-HAART, in HIV encephalitis (HIVE) and AIDS cases. This result was maximal in the hippocampus where microglial/macrophage upregulation in the HAART-treated group exceeded that seen in HIVE. In the basal ganglia, HAART-treated cases showed significantly higher levels of CD68-positive microglia/macrophages than in control brains (p = 0.004), and in the hippocampus levels were significantly higher than those seen in control cases, pre-HAART AIDS, and presymptomatic brains (p = 0.01). However, lymphocyte levels in the areas examined were low in HAART-treated cases. We conclude that there is a surprising degree of ongoing neuroinflammation in HAART-treated patients, particularly in the hippocampus. This may pose a threat for the future health of individuals maintained long-term on HAART therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0022-3069
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
529-36
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15977645-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:15977645-Adolescent,
pubmed-meshheading:15977645-Adult,
pubmed-meshheading:15977645-Antigens, CD,
pubmed-meshheading:15977645-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:15977645-Brain,
pubmed-meshheading:15977645-Central Nervous System Diseases,
pubmed-meshheading:15977645-Female,
pubmed-meshheading:15977645-Glial Fibrillary Acidic Protein,
pubmed-meshheading:15977645-Humans,
pubmed-meshheading:15977645-Immunohistochemistry,
pubmed-meshheading:15977645-Inflammation,
pubmed-meshheading:15977645-Ki-67 Antigen,
pubmed-meshheading:15977645-Male,
pubmed-meshheading:15977645-Middle Aged
|
pubmed:year |
2005
|
pubmed:articleTitle |
Influence of HAART on HIV-related CNS disease and neuroinflammation.
|
pubmed:affiliation |
Neuropathology Unit, University of Edinburgh, Alexander Donald Building, Western General Hospital, Edinburgh, Scotland.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|